Breaking News

Sphere Fluidics Unveils Cyto-Mine Chroma

The second generation of its Cyto-Mine platform accelerates and streamlines workflows across expanded applications in biotherapeutic discovery & development.

Author Image

By: Charlie Sternberg

Associate Editor

Sphere Fluidics, a provider of droplet-based microfluidics solutions for single-cell analysis and isolation, has unveiled Cyto-Mine Chroma, the second generation of its flagship Cyto-Mine platform. This new platform will offer enhanced capabilities, including multiplexing and greater assay flexibility, to further maximize the efficiency and precision of single-cell functional analysis workflows.   Cyto-Mine Chroma builds on the original Cyto-Mine platform’s ability to leverage picodroplet tech...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters